Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Frap-SERM: Fracture prevention using SERM in osteoporotic cervical cancer patients after radiotherapy
jRCT1061220067Recruiting
- Sponsor
- Hisashi Masuyama
- Start
- Oct 2022
- Countries
- 1
01
Overview
Open-label trial in osteoporosis, Cervical Cancer (CC) and pelvic insufficiency fracture (2 arms), sponsored by Hisashi Masuyama. Primary endpoint: New pelvic fractures within irradiation field at 2 years. Started Oct 2022; status: recruiting.
02
Conditions
osteoporosisCervical Cancer (CC)pelvic insufficiency fracture
Beyond the preview
Go deeper on jRCT1061220067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1061220067.